Changes in metabolic profiles during acute kidney injury and recovery following ischemia/reperfusion

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Wei, Qingqing ^a   Xiao, Xiao ^a,b   Fogle, Paul ^c   Dong, Zheng ^a,d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b WUHAN UNIVERSITY   (China)

^c METABOLON INC   (United States)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INDICAN; NITROGEN; PROSTAGLANDIN; UREA; GLUCOSE; PURINE; PURINE DERIVATIVE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CREATININE BLOOD LEVEL; ENERGY METABOLISM; KIDNEY CORTEX; KIDNEY ISCHEMIA; KIDNEY MEDULLA; KIDNEY METABOLISM; LIPID METABOLISM; MALE; METABOLOME; MOUSE; NEPHRITIS; NONHUMAN; OSMOREGULATION; PURINE METABOLISM; REPERFUSION INJURY; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; ANIMAL; CLUSTER ANALYSIS; COMPLICATION; DISEASE MODEL; INFLAMMATION; KIDNEY FUNCTION TEST; METABOLISM; METABOLOMICS; TIME;

ACUTE KIDNEY INJURY; ANIMALS; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUCOSE; INFLAMMATION; KIDNEY FUNCTION TESTS; LIPID METABOLISM; MALE; METABOLIC NETWORKS AND PATHWAYS; METABOLOME; METABOLOMICS; MICE; OSMOREGULATION; PURINES; REPERFUSION INJURY; TIME FACTORS;

EID: 84906996749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106647     Document Type: Article

References (41)

1. Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221.
2. Weiss RH, Kim K (2012) Metabolomics in the study of kidney diseases. Nat Rev Nephrol 8: 22-33.
3. Zhang A, Sun H, Qiu S, Wang X (2013) Metabolomics insights into pathophysiological mechanisms of nephrology. Int Urol Nephrol.
4. Uehara T, Horinouchi A, Morikawa Y, Tonomura Y, Minami K, et al. (2013) Identification of metabolomic biomarkers for drug-induced acute kidney injury in rats. J Appl Toxicol.
5. Noto A, Cibecchini F, Fanos V, Mussap M (2013) NGAL and metabolomics: the single biomarker to reveal the metabolome alterations in kidney injury. Biomed Res Int 2013: 612032.
6. Hanna MH, Segar JL, Teesch LM, Kasper DC, Schaefer FS, et al. (2013) Urinary metabolomic markers of aminoglycoside nephrotoxicity in newborn rats. Pediatr Res 73: 585-591.
7. Schnackenberg LK, Sun J, Pence LM, Bhattacharyya S, Gamboa da Costa G, et al. (2012) Metabolomics evaluation of hydroxyproline as a potential marker of melamine and cyanuric acid nephrotoxicity in male and female Fischer F344 rats. Food Chem Toxicol 50: 3978-3983.
8. Sun J, Shannon M, Ando Y, Schnackenberg LK, Khan NA, et al. (2012) Serum metabolomic profiles from patients with acute kidney injury: a pilot study. J Chromatogr B Analyt Technol Biomed Life Sci 893-894: 107-113.
9. Wang J, Zhou Y, Xu M, Rong R, Guo Y, et al. (2011) Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report. Transplant Proc 43: 3738-3742.
10. Atzori L, Mussap M, Noto A, Barberini L, Puddu M, et al. (2011) Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. J Matern Fetal Neonatal Med 24 Suppl 2: 40-43.
11. Zgoda-Pols JR, Chowdhury S, Wirth M, Milburn MV, Alexander DC, et al. (2011) Metabolomics analysis reveals elevation of 3-indoxyl sulfate in plasma and brain during chemically-induced acute kidney injury in mice: investigation of nicotinic acid receptor agonists. Toxicol Appl Pharmacol 255: 48-56.
12. Xie G, Zheng X, Qi X, Cao Y, Chi Y, et al. (2010) Metabonomic evaluation of melamine-induced acute renal toxicity in rats. J Proteome Res 9: 125-133.
13. Portilla D, Schnackenberg L, Beger RD (2007) Metabolomics as an extension of proteomic analysis: study of acute kidney injury. Semin Nephrol 27: 609-620.
14. Liu Y, Yan S, Ji C, Dai W, Hu W, et al. (2012) Metabolomic changes and protective effect of (L)-carnitine in rat kidney ischemia/reperfusion injury. Kidney Blood Press Res 35: 373-381.
15. Wei Q, Dong Z (2012) Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Renal Physiol 303: F1487-1494.
16. Wei Q, Dong G, Chen JK, Ramesh G, Dong Z (2013) Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule-specific knockout mouse models. Kidney Int 84: 138-148.
17. Zhang D, Liu Y, Wei Q, Huo Y, Liu K, et al. (2014) Tubular p53 Regulates Multiple Genes to Mediate AKI. J Am Soc Nephrol.
18. Wu VC, Young GH, Huang PH, Lo SC, Wang KC, et al. (2013) In acute kidney injury, indoxyl sulfate impairs human endothelial progenitor cells: modulation by statin. Angiogenesis 16: 609-624.
19. Agatsuma S, Sekino H, Watanabe H (1996) Indoxyl-beta-D-glucuronide and 3-indoxyl sulfate in plasma of hemodialysis patients. Clin Nephrol 45: 250-256.
20. Saito S, Shimizu H, Yisireyili M, Nishijima F, Enomoto A, et al. (2014) Indoxyl Sulfate-Induced Activation of (Pro)Renin Receptor Is Involved in Expression of TGF-beta1 and alpha-Smooth Muscle Actin in Proximal Tubular Cells. Endocrinology 155: 1899-1907.
21. Yisireyili M, Shimizu H, Saito S, Enomoto A, Nishijima F, et al. (2013) Indoxyl sulfate promotes cardiac fibrosis with enhanced oxidative stress in hypertensive rats. Life Sci 92: 1180-1185.
22. Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T (2013) Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NFkappaB. BMC Nephrol 14: 56.
23. Shimizu H, Yisireyili M, Nishijima F, Niwa T (2013) Indoxyl sulfate enhances p53-TGF-beta1-Smad3 pathway in proximal tubular cells. Am J Nephrol 37: 97-103.
24. Shimizu H, Yisireyili M, Higashiyama Y, Nishijima F, Niwa T (2013) Indoxyl sulfate upregulates renal expression of ICAM-1 via production of ROS and activation of NF-kappaB and p53 in proximal tubular cells. Life Sci 92: 143-148.
25. Zhan M, Brooks C, Liu F, Sun L, Dong Z (2013) Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83: 568-581.
26. Hauet T, Baumert H, Gibelin H, Godart C, Carretier M, et al. (2000) Citrate, acetate and renal medullary osmolyte excretion in urine as predictor of renal changes after cold ischaemia and transplantation. Clin Chem Lab Med 38: 1093-1098.
27. Ogata F, Hirasawa Y, Takahashi S, Tajiri M, Kanno K, et al. (1981) Disturbance of serum lipid metabolism in acute renal failure. Clin Exp Dial Apheresis 5: 361-371.
28. Iwata M, Herrington J, Zager RA (1995) Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance. Proc Natl Acad Sci U S A 92: 8970-8974.
29. Zager RA, Conrad DS, Burkhart K (1998) Ceramide accumulation during oxidant renal tubular injury: mechanisms and potential consequences. J Am Soc Nephrol 9: 1670-1680.
30. Zager RA, Iwata M, Conrad DS, Burkhart KM, Igarashi Y (1997) Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 52: 60-70.
31. Woodcock J (2006) Sphingosine and ceramide signalling in apoptosis. IUBMB Life 58: 462-466.
32. Park SW, Kim M, Chen SW, D'Agati VD, Lee HT (2010) Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock 33: 31-42.
33. Vary TC, Angelakos ET, Schaffer SW (1979) Relationship between adenine nucleotide metabolism and irreversible ischemic tissue damage in isolated perfused rat heart. Circ Res 45: 218-225.
34. Lee HT, Emala CW (2001) Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation. Am J Kidney Dis 38: 610-618.
35. Fitzpatrick JM, Wallace DM, Whitfield HN, Watkinson LE, Fernando AR, et al. (1981) Inosine in ischaemic renal surgery: long-term follow-up. Br J Urol 53: 524-527.
36. Kelly KJ, Plotkin Z, Vulgamott SL, Dagher PC (2003) P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138.
37. Yagihashi S, Mizukami H, Ogasawara S, Yamagishi S, Nukada H, et al. (2010) The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice. J Pathol 220: 530-541.
38. Kinsey GR, Sharma R, Okusa MD (2013) Regulatory T cells in AKI. J Am Soc Nephrol 24: 1720-1726.
39. Paller MS, Manivel JC (1992) Prostaglandins protect kidneys against ischemic and toxic injury by a cellular effect. Kidney Int 42: 1345-1354.
40. Lau T, Owen W, Yu YM, Noviski N, Lyons J, et al. (2000) Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 105: 1217-1225.
41. Schulman G (2012) A nexus of progression of chronic kidney disease: tryptophan, profibrotic cytokines, and charcoal. J Ren Nutr 22: 107-113.